Ibrutinib improves PFS by 50% for older patients with newly diagnosed mantle cell lymphoma
Ibrutinib improves PFS by 50% for older patients with newly diagnosed mantle cell lymphoma
N-803-BCG combination shows promising results in BCG-unresponsive NMIBC
Comment: Sacituzumab govitecan for HR+/HER2‐ advanced breast cancer
Circulating tumour DNA analysis can help identify the need for adjuvant therapy in stage II colon cancer
UICC announces global coalition to increase access to essential cancer medicines in low and lower middle-income countries
ASCO and WHO to collaborate on quality indicators for cancer facilities
Sacituzumab govitecan increases PFS for HR+/HER2- metastatic breast cancer
Ramucirumab plus pembrolizumab improves OS in advanced NSCLC
Cancer Services Delivery: Focus on India
Outcomes of clinico-radiologically advanced cancer (cT4b) of buccal mucosa: A retrospective analysis of 104 patients
The role of the Global Coalition for Radiotherapy in the war in Ukraine
Youth Cancer Europe: Aiding Ukrainian refugees during the crisis